Abeona Therapeutics Wts

ABEOW

9.41

0.00

0.0%

Please Login or Register

Login|Register FREE

Please Login or Register

Login|Register FREE

Stock Price
Open: 9.41
Prev. Close: 9.41
Low/Hi: 9.41 - 9.41
52-Week: 3.52 - 17.56
Volumes
Equity:
90-Day Avg: 1,086
Volatility
Todays Stock Vol: 0.0
20-Day (HV): 86.5
52-Week (HV): 130.0
Fundamental
Div. Yield:
Stock Info
Type: Warrant
Sector: N/A
Industry: N/A

About ABEOW

Abeona Therapeutics, Inc. develops and delivers gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona's lead programs are AB0-101 (AAV9 NAGLU) and ABO-102 (scAAV9 SGSH), adeno-associated virus (AAV)-based gene therapies for Sanfilippo syndrome (MPS IIIB and IIIA) in collaboration with patient advocate groups, researchers and clinicians, anticipated to commence clinical trials in 2015. They are also developing ABO-201 (scAAV9 CLN3) gene therapy for juvenile Batten disease (JBD); and ABO-301 (AAV LK19 FANCC) for Fanconi anemia (FA) disorder using a novel CRISPR/Cas9-based gene editing approach to gene therapy program for rare blood diseases. In addition are also developing rare plasma protein therapies including SDF Alpha (alpha-1 protease inhibitor) for inherited COPD using our proprietary SDF (Salt Diafiltration) ethanol-free process.
Primary Exchange: NASDAQ

Wait, Before You Leave...